Erythrocyte-protective effect of sarpogrelate hydrochloride (Anplag^®), a selective 5-HT₂ receptor antagonist: an in vitro study

By Nakamura Ken   Kawahito Koji  

Journal of Artificial Organs, Vol. 13, Iss. 3, 2010-09 ,pp. : 178-181

Springer Publishing Company

Access to resources Recommend Favorite

Cilansetron: a novel, high-affinity 5-HT₃ receptor antagonist for irritable bowel syndrome with diarrhea predominance

By Coremans Georges  

Therapy, Vol. 2, Iss. 4, 2005-07 ,pp. : 559-567

Future Medicine

Access to resources Recommend Favorite

QoL evaluation of olanzapine for chemotherapy‐induced nausea and vomiting comparing with 5‐HT3 receptor antagonist

By  

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 24, Iss. 3, 2015-05 ,pp. : 436-443

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic actions of 5‐HT3R antagonists for POI

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 4, 2015-02 ,pp. : 1136-1147

John Wiley & Sons Inc

Access to resources Recommend Favorite

Changes in Plasma Serotonin Concentration and Acceleration Plethysmograms in Patients with Raynaud's Phenomenon after Long‐term Treatment with a 5‐HT2 Receptor Antagonist

By  

THE JOURNAL OF DERMATOLOGY, Vol. 27, Iss. 10, 2000-10 ,pp. : 643-650

John Wiley & Sons Inc

Access to resources Recommend Favorite